Company / Operating Cash Flow per Share
Arrowhead Pharmaceuticals Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.44
FY2025
5-year range
-$4.31 / $1.67
FY2021-FY2025
Trend
+133.5%
vs FY2024
Sector context
#48 of 212
Health Care
What the data says
Arrowhead Pharmaceuticals's operating cash flow per share of $1.44 is higher than 77% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-4.31 in FY2024 to $1.67 in FY2021.
Based on SEC 10-K filings.
1.44 in FY2025. Top quartile in the Health Care sector.
Declined from $1.62 to $1.44 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+109.8% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 133.5% year-over-year.
- Ranks #48 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.44 | +133.5% |
| FY2024 | -$4.31 | -366.8% |
| FY2023 | $1.62 | +276.1% |
| FY2022 | -$0.92 | -154.9% |
| FY2021 | $1.67 | +266.8% |
| FY2020 | -$1.00 | -270.9% |
| FY2019 | -$0.27 | +68.6% |
| FY2018 | -$0.86 | +8.6% |
| FY2017 | -$0.94 | +12.9% |
| FY2016 | -$1.08 | -210.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026